Poster - #VH-71109 - Keywords: UCSF OTOP Contingency Management Stimulant Use Disorder

Contingency Management for Stimulant Use Disorder Improves Overall Retention within Opiate Treatment Outpatient Program

Janaya Jones, B.S, John Dunham, M.A., Caravella McCuistian, PhD., Bradley Shapiro, M.D.
University of California, San Francisco

ABSTRACT:
Stimulant use is a growing public health concern (Compton et al., 2018). Unlike opioid use disorder, which has FDA approved medications such as methadone and buprenorphine, there are no FDA approved pharmacotherapies for stimulant use disorder (Liu, 2021). This gap in treatment is relevant in Opioid Treatment Programs (OTPs), where the primary focus is on opioid use and additional stimulant use treatments may not be a standard practice. Interventions like contingency management could help bridge this gap and support patient engagement in treatment.

Contingency management (CM) is an evidence based behavioral intervention that has been shown to reduce stimulant use (Bolivar et al., 2021). By addressing stimulant use, CM can promote positive outcomes for participants, such as increased engagement (Bolivar et al., 2021).

In July 2023, the Opiate Treatment Outpatient Program (OTOP) located at the Zuckerberg San Francisco General Hospital (ZSFGH) campus initiated the Recovery Incentives Program, which provides contingency management to reduce stimulant use among patients seeking medication treatment for opioid use disorder (OUD). This quality improvement study examined the impact of the Recovery Incentives Program on retention in the Opiate Treatment Outpatient Program.